联邦制药(03933)：约336.98万股奖励股份获归属

Core Viewpoint - The company, 联邦制药, announced the issuance of 3.3698 million shares as part of its 2023 share award plan, contingent upon the achievement of performance targets for 2024, with the shares set to vest on November 13, 2025 [1] Summary by Category - Share Issuance: A total of 3.3698 million shares will be awarded under the 2023 share award plan [1] - Performance Conditions: The vesting of these shares is dependent on the achievement of specific performance targets for the year 2024 [1] - Vesting Date: The shares are scheduled to vest on November 13, 2025 [1]